Activation of Rho GTPases in Smith–Lemli–Opitz syndrome: pathophysiological and clinical implications

Myosin-II negatively regulates minor process extension and the temporal development of neuronal polarity

(2009) K.M. Kollins et al.   Developmental Neurobiology

Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and management

(2008) Forbes D Porter   EUROPEAN JOURNAL OF HUMAN GENETICS

Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome

(2008) M. L. Lindegaard et al.   HUMAN MOLECULAR GENETICS

Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule

(2008) Takekazu Kubo et al.   JOURNAL OF NEUROCHEMISTRY

A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model

(2008) B. C. Capell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diverse roles of Rho family GTPases in neuronal development, survival, and death

(2007) Daniel et al.   Frontiers in Bioscience-Landmark